Drug Shortage Report for APO-NAPROXEN SR TABLETS 750MG

Last updated on 2017-10-05 History
Report ID 19015
Drug Identification Number 02177072
Brand name APO-NAPROXEN SR TABLETS 750MG
Common or Proper name NAPROXEN
Company Name APOTEX INC
Market Status DORMANT
Active Ingredient(s) NAPROXEN
Strength(s) 750MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 100 BTL
ATC code M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-03-10
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2017-10-05
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2017-08-13 French Compare
v1 2017-08-13 English Compare